378 results
8-K
EX-99.1
REGN
Regeneron Pharmaceuticals, Inc.
2 May 24
Regeneron Reports First Quarter 2024 Financial and Operating Results
7:06am
, the Company's GAAP effective tax rate (ETR) was (3.0%), compared to 4.7% in the first quarter of 2023. The GAAP ETR in the first quarter of 2024 … million
$780–$880 million
GAAP effective tax rate
Non-GAAP effective tax rate(a)
Unchanged
* GAAP and non-GAAP amounts are equivalent as no non-GAAP
8-K
EX-99.1
igji0a28q zalzup
2 Feb 24
Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
7:16am
8-K
etkiep1jn4 kk26z3v
8 Jan 24
2 Strategy & Business Update J.P.Morgan Healthcare Conference 2024 Co - Founder, Board Co - Chair, President & Chief Executive Officer
6:30am
8-K
EX-99.1
u5yxcezbs0a u6j
2 Nov 23
Regeneron Reports Third Quarter 2023 Financial and Operating Results
7:10am
8-K
ujfqlkywi9 t8inequ
5 Oct 23
Results of Operations and Financial Condition
4:04pm
SC TO-T
EX-99
q0p xvyu52aw
25 Aug 23
Third party tender offer statement
7:46am
SC TO-T
EX-99
d7j7xhcitnyr
25 Aug 23
Third party tender offer statement
7:46am
SC TO-T
EX-99
lzn0c gyt3lx6yk
25 Aug 23
Third party tender offer statement
7:46am
SC TO-T
EX-99
82yt8u3roow
25 Aug 23
Third party tender offer statement
7:46am
8-K
EX-99.1
e7c61
3 Aug 23
Regeneron Reports Second Quarter 2023 Financial and Operating Results
6:48am
8-K
EX-99.1
bjwkopo54ma b3cfii
4 May 23
Regeneron Reports First Quarter 2023 Financial and Operating Results
7:11am